Annual Net Income
-$28.54 M
-$1.96 M-7.38%
30 September 2024
Summary:
ESSA Pharma annual net profit is currently -$28.54 million, with the most recent change of -$1.96 million (-7.38%) on 30 September 2024. During the last 3 years, it has risen by +$8.26 million (+22.45%). EPIX annual net income is now -1464.93% below its all-time high of -$1.82 million, reached on 30 September 2014.EPIX Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Net Income
-$6.36 M
+$878.50 K+12.14%
30 September 2024
Summary:
ESSA Pharma quarterly net profit is currently -$6.36 million, with the most recent change of +$878.50 thousand (+12.14%) on 30 September 2024. Over the past year, it has dropped by -$873.90 thousand (-15.94%). EPIX quarterly net income is now -276.91% below its all-time high of $3.59 million, reached on 30 June 2017.EPIX Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Net Income
-$28.54 M
-$873.90 K-3.16%
30 September 2024
Summary:
ESSA Pharma TTM net profit is currently -$28.54 million, with the most recent change of -$873.90 thousand (-3.16%) on 30 September 2024. Over the past year, it has dropped by -$1.96 million (-7.37%). EPIX TTM net income is now -12234.79% below its all-time high of -$231.40 thousand, reached on 31 December 2013.EPIX TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
EPIX Net Income Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -7.4% | -15.9% | -7.4% |
| 3 y3 years | +22.4% | +25.8% | +22.4% |
| 5 y5 years | -123.8% | -91.7% | -123.8% |
EPIX Net Income High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -7.4% | +22.4% | -15.9% | +41.5% | -10.6% | +27.5% |
| 5 y | 5 years | -123.8% | +22.4% | -91.7% | +51.0% | -123.8% | +27.5% |
| alltime | all time | -1464.9% | +22.4% | -276.9% | +51.0% | <-9999.0% | +27.5% |
ESSA Pharma Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | -$28.54 M(+7.4%) | -$6.36 M(-12.1%) | -$28.54 M(+3.2%) |
| June 2024 | - | -$7.23 M(-19.5%) | -$27.67 M(-0.2%) |
| Mar 2024 | - | -$8.99 M(+50.7%) | -$27.73 M(+7.5%) |
| Dec 2023 | - | -$5.96 M(+8.8%) | -$25.80 M(-2.9%) |
| Sept 2023 | -$26.58 M(-24.3%) | -$5.48 M(-24.9%) | -$26.58 M(-3.1%) |
| June 2023 | - | -$7.30 M(+3.4%) | -$27.43 M(-5.3%) |
| Mar 2023 | - | -$7.06 M(+4.7%) | -$28.95 M(-11.6%) |
| Dec 2022 | - | -$6.74 M(+6.6%) | -$32.75 M(-6.7%) |
| Sept 2022 | -$35.10 M(-4.6%) | -$6.32 M(-28.4%) | -$35.10 M(-6.0%) |
| June 2022 | - | -$8.83 M(-18.7%) | -$37.34 M(+0.2%) |
| Mar 2022 | - | -$10.85 M(+19.3%) | -$37.26 M(-5.4%) |
| Dec 2021 | - | -$9.10 M(+6.3%) | -$39.37 M(+7.0%) |
| Sept 2021 | -$36.81 M(+57.0%) | -$8.56 M(-2.2%) | -$36.81 M(+12.2%) |
| June 2021 | - | -$8.75 M(-32.5%) | -$32.80 M(+13.2%) |
| Mar 2021 | - | -$12.97 M(+98.6%) | -$28.97 M(+14.2%) |
| Dec 2020 | - | -$6.53 M(+43.4%) | -$25.36 M(+8.2%) |
| Sept 2020 | -$23.45 M(+83.8%) | -$4.55 M(-7.5%) | -$23.45 M(+5.6%) |
| June 2020 | - | -$4.92 M(-47.4%) | -$22.21 M(+7.9%) |
| Mar 2020 | - | -$9.35 M(+102.8%) | -$20.58 M(+40.4%) |
| Dec 2019 | - | -$4.61 M(+39.2%) | -$14.66 M(+14.9%) |
| Sept 2019 | -$12.76 M | -$3.31 M(+0.4%) | -$12.76 M(+8.9%) |
| June 2019 | - | -$3.30 M(-3.7%) | -$11.72 M(+3.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2019 | - | -$3.43 M(+26.6%) | -$11.30 M(-7.8%) |
| Dec 2018 | - | -$2.71 M(+19.0%) | -$12.25 M(+5.3%) |
| Sept 2018 | -$11.63 M(+158.5%) | -$2.28 M(-21.0%) | -$11.63 M(+2.9%) |
| June 2018 | - | -$2.88 M(-34.3%) | -$11.30 M(+134.1%) |
| Mar 2018 | - | -$4.38 M(+109.7%) | -$4.83 M(-40.1%) |
| Dec 2017 | - | -$2.09 M(+7.4%) | -$8.05 M(+79.0%) |
| Sept 2017 | -$4.50 M(-65.8%) | -$1.95 M(-154.2%) | -$4.50 M(-33.7%) |
| June 2017 | - | $3.59 M(-147.2%) | -$6.79 M(-52.3%) |
| Mar 2017 | - | -$7.61 M(-619.7%) | -$14.25 M(+85.3%) |
| Dec 2016 | - | $1.46 M(-134.6%) | -$7.69 M(-41.5%) |
| Sept 2016 | -$13.14 M(+35.8%) | -$4.24 M(+9.6%) | -$13.14 M(+56.1%) |
| June 2016 | - | -$3.87 M(+267.5%) | -$8.42 M(-14.5%) |
| Mar 2016 | - | -$1.05 M(-73.6%) | -$9.84 M(-20.2%) |
| Dec 2015 | - | -$3.99 M(-917.1%) | -$12.34 M(+27.5%) |
| Sept 2015 | -$9.68 M(+430.5%) | $487.70 K(-109.2%) | -$9.68 M(-9.0%) |
| June 2015 | - | -$5.29 M(+49.0%) | -$10.63 M(+68.1%) |
| Mar 2015 | - | -$3.55 M(+167.8%) | -$6.33 M(+117.1%) |
| Dec 2014 | - | -$1.33 M(+182.8%) | -$2.91 M(+60.1%) |
| Sept 2014 | -$1.82 M | -$468.70 K(-52.2%) | -$1.82 M(+34.7%) |
| June 2014 | - | -$981.40 K(+611.7%) | -$1.35 M(+265.7%) |
| Mar 2014 | - | -$137.90 K(-40.4%) | -$369.30 K(+59.6%) |
| Dec 2013 | - | -$231.40 K | -$231.40 K |
FAQ
- What is ESSA Pharma annual net profit?
- What is the all time high annual net income for ESSA Pharma?
- What is ESSA Pharma annual net income year-on-year change?
- What is ESSA Pharma quarterly net profit?
- What is the all time high quarterly net income for ESSA Pharma?
- What is ESSA Pharma quarterly net income year-on-year change?
- What is ESSA Pharma TTM net profit?
- What is the all time high TTM net income for ESSA Pharma?
- What is ESSA Pharma TTM net income year-on-year change?
What is ESSA Pharma annual net profit?
The current annual net income of EPIX is -$28.54 M
What is the all time high annual net income for ESSA Pharma?
ESSA Pharma all-time high annual net profit is -$1.82 M
What is ESSA Pharma annual net income year-on-year change?
Over the past year, EPIX annual net profit has changed by -$1.96 M (-7.38%)
What is ESSA Pharma quarterly net profit?
The current quarterly net income of EPIX is -$6.36 M
What is the all time high quarterly net income for ESSA Pharma?
ESSA Pharma all-time high quarterly net profit is $3.59 M
What is ESSA Pharma quarterly net income year-on-year change?
Over the past year, EPIX quarterly net profit has changed by -$873.90 K (-15.94%)
What is ESSA Pharma TTM net profit?
The current TTM net income of EPIX is -$28.54 M
What is the all time high TTM net income for ESSA Pharma?
ESSA Pharma all-time high TTM net profit is -$231.40 K
What is ESSA Pharma TTM net income year-on-year change?
Over the past year, EPIX TTM net profit has changed by -$1.96 M (-7.37%)